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ompletion Angiography After
oronary Artery Bypass Grafting
r Routine Intraoperative Transit
ime Flow Measurement to
heck Graft’s Quality?
e have read with great interest the study by Zhao et al. (1),
hich concluded that intraoperative coronary angiography should
erhaps eventually become the standard of care for coronary artery
ypass grafting (CABG) surgery. We ask, is it really necessary to
erform it routinely? They showed that a hybrid operating room is
seful and provides a good quality control of CABG surgery. The
ybrid revascularization procedure is certainly indicated for specific
atient conditions (e.g., poor conduits, ungraftable vessels, stent-
ng of the left subclavian artery). However, we have some concerns
bout the conclusion of this study.
Our group has begun to assess the surgical results of CABG
urgery using transit time flow measurement. Our experience
ndicates that a meticulous method of assessing intraoperative flow
easurements can improve the quality of the surgery performed
nd increases the accuracy of diagnosing technical problems with
ewly constructed bypass grafts for both off- and on-pump
rocedures (2). The transit time flow measurement has already
een demonstrated to be safe, easy to perform, reproducible, and
heap. In a patent coronary graft, the hemodynamics are similar to
hose physiologically observed in the coronary circulation: blood
ows mainly during diastole with minimal systolic peaks taking
lace during the isovolumetric ventricular contraction (QRS com-
lex) (3).
In accordance with the interesting editorial comment (4), we do
ot currently see any clinical evidence that justifies the need to
heck all performed CABG with an immediate post-operative
ngiography, with the consequent significant increase in the costs
nd morbidity, when there is already available a useful and cheap
evice to assess the quality of the revascularization. We consider
he post-operative angiography a very important tool that should
e reserved for specific cases only (e.g., post-operative ischemia,
ow cardiac output syndrome, technical problems during surgery).
Finally, Zhao et al. (1) showed that the routine use of angiog-
aphy revealed graft defects in 89 patients (12%) of their study
opulation of 366 patients; they performed a total arterial
evascularization with either double internal thoracic artery or
adial artery in only 2% of cases. These data are completely in
ontrast to the general trend that is ongoing in cardiac surgery
s recently shown by the SYNTAX (Synergy between PCI with
axus and Cardiac Surgery) trial and registry (27.6% and
6.1%, respectively) (5). oAndrea Colli, MD
avier Ruyra, MD
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e appreciate the comments of Drs. Colli and Ruyra regarding
ur paper (1) and the indications for routine completion angiog-
aphy after coronary artery bypass grafting (CABG) surgery. We
gree with Dr. Colli and colleagues that the transit time flow meter
TTFM) is a valuable tool to assess intraoperative graft patency.
oreover, it is relatively inexpensive and readily available in those
enters that do not have an operating room with angiography
apability. The TTFM, however, has several limitations. It is
easonably accurate in defining graft integrity only at the extremes,
hich is either patent or occluded, while it cannot define location
f the defect either within the conduit or at the anastomosis.
oreover, it cannot discriminate between the influences of the
onduit versus the native coronary arteriolar bed. Also, the normal
ange values have very large variability because TTFM measures
he mean graft flow, which is influenced by the systemic arterial
ressure, cardiac output, type of conduit used (vein conduit vs.
rterial conduit), residual antegrade coronary flow, resistance of the
istal coronary bed flow, competitive native flow, and, finally,
lood hematocrit (2). Thus, for those grafts with values between
he abnormal and normal range, there is a lack of sensitivity for
bjective clear cutoff values.
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December 8, 2009:2337–41For the reasons mentioned in the preceding text, coronary
ngiography can identify a higher rate of defective grafts compared
ith TTFM (3). The rate of graft revision based on TTFM is
etween 1% to 8% (2). These rates are well below the average 20%
o 30% 1-year saphenous vein graft (SVG) failure rate reported in
he literature (2,4). The PREVENT IV (PRoject of Ex-vivo Vein
raft ENgineering via Transfection IV) trial, a multicenter ran-
omized study of 3,041 patients, has confirmed the clinical impact
f vein graft failure. In this study, the common end point of death
nd new myocardial infarction was 0.9% in patients with patent
VG, while for patients with at least 1 occluded SVG this adverse
utcome was 14% (p  0.001) (4).
In order to improve the long-term outcomes of CABG surgery,
raft patency is a key factor. Grafts fail early primarily because of
echnical errors that could be corrected at the time of the surgery.
hile the TTFM and other techniques such as intraoperative
uorescence imaging are steps toward improving graft patency,
hey can identify only a limited number of graft defects, mostly
cclusive abnormalities, and cannot reliably identify significant
50%) nonocclusive graft flow abnormalities. These significant
raft abnormalities have important clinical impact on the long-
erm benefits provided by CABG surgery. For the reasons men-
ioned in the preceding text, routine angiography after CABG has
ow periprocedural morbidity. It seems that it should perhaps
ventually be routine if available in a hybrid suite.
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he SoS Acronym
he term “acronym” has been used since World War II. It referso an abbreviation created from the first letters of each word in a oeries of words. Typical examples are NATO (North Atlantic
reaty Organization) and SOS (Save our Souls).
Acronyms are frequently being used to refer to clinical trials,
ften with some difficulty. Occasionally even the PI (Primary
nvestigator) cannot remember the background of such
bbreviations.
In 1995 we embarked in a clinical trial comparing 2 treatment
ptions for myocardial revascularization, the use of stents versus
urgery. We simply called the trial SoS (Stent or Surgery) (1). The
esults of this trial have been published in leading journals, and the
tudy is still ongoing.
In the March 27, 2009, issue of the Journal (2), another SOS
rial was published. The authors decided to use the same, previ-
usly employed acronym to describe a comparison of different
tents for the treatment of saphenous vein grafts. The acronym
OS stands in this context for “a randomized controlled trial of a
aclitaxel-eluting stent versus a similar bare-metal stent in saphe-
ous vein graft lesions: the SOS (Stenting of Saphenous vein grafts
rial);” the association, apart from the infringement with previous
nd future SOS publications, seems far-fetched.
Even in the absence of legal guidelines, the reutilization of
stablished acronyms (in particular, if they are still in use) should
e discouraged. Authors and editors ought to adopt some common
ense to avoid confusion.
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eply
cronyms are an important component of clinical trials and may
erve several roles, such as facilitating reference to the trial, creating
nthusiasm about the trial, and promoting recruitment. SOS is a
rief and memorable acronym that is particularly well suited for
rials, as it invokes a call for help to which many patients might
espond. Indeed, SOS is a widely used trial acronym: a search for
OS in the clinical trials website on July 13, 2009, retrieved 28
esults, ranging from the “Stent or Surgery” trial (NCT00475449)
o “Systems of Support to Increase Colon Cancer Screening
nd Follow-up” (NCT00697047) to “Stroke Oxygen study”
ISRCTN52416964) or the “SAFE OR SORRY?” trial
NCT00365430).
In 1987, the Swedish Obese Subjects study was initiated, and
ver the ensuing 2 decades it critically evaluated the effects of
